111 filings
Page 2 of 6
DEFA14A
lot5gr
27 Apr 23
Additional proxy soliciting materials
8:06am
8-K
tw9ul3
10 Mar 23
Regulation FD Disclosure
4:34pm
ARS
1h4m uwihs84
8 Mar 23
Annual report to shareholders
7:32am
8-K
91xqnuxuwc80 iwe2nr
8 Mar 23
Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent
7:05am
8-K
2w4qqyd
16 Feb 23
Entry into a Material Definitive Agreement
5:04pm
424B5
fcu9bcc
15 Feb 23
Prospectus supplement for primary offering
5:32pm
8-K
rki3egs2hm zy
15 Feb 23
Results of Operations and Financial Condition
8:24am
8-K
cjpqcy8
25 Jan 23
Other Events
4:10pm
8-K
sm01yvplx1u24ly7 3k
12 Dec 22
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
8:00am
8-K
enwvuk4oa38wlqe60krl
9 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:11pm
8-K
akpo05 p9s
9 Nov 22
Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
7:06am
8-K
63lcbjw3smrcqcqm63ip
26 Oct 22
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
1:41pm
8-K
ol033f
9 Aug 22
Galera Reports Second Quarter 2022 Financial Results and Recent Corporate Updates
7:00am
8-K
tbyfxm4 dmlmnz
16 Jun 22
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
bit2fn1 t582uefi66
10 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm